Legend Biotech

#ICYMI: Big things are happening in #Philadelphia! Last week, Legend officially opened our new state-of-the-art R&D facility. This milestone reflects more than growth in space; it’s a testament to our team’s dedication, our mission to advance next-generation therapies, and our commitment to a future where #Cancers and intractable diseases are curable. Read more about our expansion: https://lnkd.in/edSzTvhS

November is a time to shine a light on #GastrointestinalCancers.      Today, on #WorldPancreaticCancerDay, we stand with the global community, raising awareness of the ongoing need for research and innovation. We also recognize the importance of advancing new therapies for #StomachCancer.     At Legend, we are committed to advancing #CellTherapies and #Oncology research to bring new hope and treatment options to patients. Innovations in research today can make a meaningful difference for patients tomorrow. 

Tomorrow, our President of Carvykti, Alan Bash, will participate in a fireside chat taking place at 12:45 pm ET during Fierce Biotech's Cell & Gene Therapy virtual event.     He’ll dive into the evolving world of #CellTherapies, sharing firsthand insights on innovation, challenges, and the potential to transform outcomes in #MultipleMyeloma and beyond.     Register here for the virtual event: https://lnkd.in/ePrXrDNJ

#LegendNews: We were excited to officially open our new state-of-the-art R&D facility in #Philadelphia, purpose-built to accelerate innovation in #CellTherapy.     Our expanding Philly team will play a crucial role in advancing Legend’s next-generation pipeline and strengthening our footprint in one of the nation’s leading #Biotech hubs. Together with our U.S. and global R&D teams, we’re committed to bringing transformative therapies closer to patients.     Thank you to our team, community members, and advocacy partners, including Life Sciences Pennsylvania, for celebrating this milestone with us.       Read more: https://lnkd.in/edSzTvhS

#LegendNews: Today, we shared our third-quarter 2025 financial results. Our CEO, Ying Huang, reflects on our #CART #CellTherapies, key milestones & what’s ahead for $LEGN. Read the highlights: https://lnkd.in/e7Ugb7Am

We’re excited to share that our VP of Clinical Development, Nitin Patel, and Sarah Snykers, Sr. Director of Operations at Legend, will be presenting at the NextGen Biomed by Oxford Global #Cell2025 event in London, taking place November 10-12!    They’ll explore the clinical and commercial manufacturing readiness of our #CART #CellTherapy, sharing key insights from late-stage development and how #CellTherapies are advancing toward broader clinical adoption and commercial scale-up.     See the agenda and discover more about the conference: https://lnkd.in/g2vP-yEb 

This month is #NationalFamilyCaregiverMonth, and our team celebrates the incredible dedication and compassion of #Caregivers everywhere.    Caregivers are often the unsung heroes in the lives of patients and families, offering support, strength, and hope every day.     To all caregivers – we recognize the vital role you play in the lives of so many and are inspired by your resilience, compassion, and the comfort you bring to those you care for. Thank you for everything you do to make a difference in the lives of others.      #PatientImpact #MakingADifference

Our CEO, Ying Huang, recently spoke with New Jersey Monthly Magazine on the impact of our #CART #CellTherapy, developed in partnership with Johnson & Johnson Innovative Medicine, and the promise of #CellTherapies for patients living with #MultipleMyeloma. In this month’s issue, Ying shares insights on how Legend is driving #innovation to make transformative therapies more accessible and how our teams in #NewJersey and around the world are working to change the treatment landscape for people facing #Cancer. Read the full story: https://lnkd.in/ew7ySY8D

This month, we pause to recognize the patients, families, and caregivers affected by #LungCancer and the ongoing efforts to advance research and treatments. Our teams are committed to developing #CellTherapy solutions that can make a meaningful difference for those living with #LungCancers, knowing that every step forward brings hope to patients and their families. We’re proud to support the #Oncology community in raising awareness, improving care, and driving hope. #LungCancerAwarenessMonth #PatientImpact #InnovationInHealthcare

#LegendNews: Join us at the American Society of Hematology's Annual Meeting, where we will present 2 orals and 6 posters on our #CART #CellTherapy in #MultipleMyeloma. We’ll also present first-in-human data on our CAR-T cell therapy in #NonHodgkinsLymphoma. If you’re attending, stop by our booth (#401) to meet the team and learn more about our oral and poster presentations. More info on our presentations at #ASH25: https://lnkd.in/gyxUW22M